Ondansetron Hydrochloride
Product Images NDC 45865-509

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 45865-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (509)

Pdp (509)
ONDANSETRON HCL Tablets 4mg are a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. It should be taken as directed by a healthcare professional. The additional characters "seneIc o zosman" are not readable and have no apparent relevance to the description.*
FDA Label Image

Chemical Structure (Ondansetron Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.